Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
As reported for the quarter ended December 31, 2018. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| BI Baxter Intl Inc | 6.5% | Unchanged | 85,933 | $5.66M |
| A Athenex Inc | 6.2% | Unchanged | 429,046 | $5.45M |
| ZB Zimmer Biomet Hldgs Inc | 5.7% | Unchanged | 47,684 | $4.95M |
| Abbvie Inc | 5.3% | Unchanged | 50,420 | $4.65M |
| Incyte Corp | 5.3% | Unchanged | 72,196 | $4.59M |
| Quanterix Corp | 4.7% | Unchanged | 223,949 | $4.1M |
| C Celgene Corp | 4.6% | Unchanged | 63,159 | $4.05M |
| Amgen Inc | 4.5% | Unchanged | 20,110 | $3.92M |
| Medtronic PLC | 3.8% | Unchanged | 36,180 | $3.29M |
| Q Quotient Ltd | 3.7% | Unchanged | 526,932 | $3.23M |
| PP Pacira Pharmaceuticals Inc | 3.7% | Unchanged | 74,502 | $3.21M |
| Takeda Pharmaceutical Co Ltd | 3.4% | Unchanged | 177,260 | $2.98M |
| AL Abbott Labs | 3.2% | Unchanged | 38,585 | $2.79M |
| Zai Lab Ltd | 3.2% | Unchanged | 120,092 | $2.79M |
| MN Mylan N V | 3.1% | Unchanged | 99,410 | $2.72M |
| Polarityte Inc | 2.8% | Unchanged | 182,833 | $2.47M |
| Viewray Inc | 2.8% | Unchanged | 397,375 | $2.41M |
| Regeneron Pharmaceuticals | 2.5% | Unchanged | 5,792 | $2.16M |
| TP Teva Pharmaceutical Inds Ltd | 2.5% | Unchanged | 139,531 | $2.15M |
| A Akorn Inc | 2.5% | Unchanged | 634,046 | $2.15M |
| Haemonetics Corp | 2.4% | Unchanged | 21,220 | $2.12M |
| Argenx Se | 1.8% | Unchanged | 16,712 | $1.61M |
| BP Biohaven Pharmactl Hldg Co L | 1.6% | Unchanged | 38,319 | $1.42M |
| MM Merit Med Sys Inc | 1.6% | Unchanged | 25,092 | $1.4M |
| S Sanofi | 1.5% | Unchanged | 30,240 | $1.31M |
| GP Gw Pharmaceuticals PLC | 1.5% | Unchanged | 13,460 | $1.31M |
| Livanova PLC | 1.3% | Unchanged | 11,974 | $1.1M |
| MT Molecular Templates Inc | 1.1% | Unchanged | 243,839 | $985K |
| FP Foamix Pharmaceuticals Ltd | 1.1% | Unchanged | 146,432 | $960K |
| Verrica Pharmaceuticals Inc | 1.1% | Unchanged | 114,947 | $937K |
| Neurocrine Biosciences Inc | 1.0% | Unchanged | 12,266 | $876K |
| Dentsply Sirona Inc | 0.9% | Unchanged | 20,347 | $757K |
| AM Axonics Modulation Tech Inc | 0.8% | Unchanged | 46,485 | $702K |
| AS Arya Sciences Acquisition Co | 0.6% | Unchanged | 50,500 | $522K |
| Adma Biologics Inc | 0.5% | Unchanged | 182,100 | $435K |
| Madrigal Pharmaceuticals Inc | 0.4% | Unchanged | 2,890 | $326K |
| Arvinas Inc | 0.4% | Unchanged | 24,210 | $311K |
| Novavax Inc | 0.3% | Unchanged | 155,320 | $286K |
| NT Neos Therapeutics Inc | 0.3% | Unchanged | 168,642 | $278K |
| Anaptysbio Inc | 0.1% | Unchanged | 1,493 | $95K |
Loading...
